A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.
Experimental Drug Acquiring Traction Online
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these profiles privately for source information, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day British shipping. Vendors promote the drug there before redirecting customers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Professionals Voice Worries
However, doctors and chemists have cautions that the distribution of what remains an unapproved medication in the UK is worrisome and could lead to individuals administering products of uncertain source.
Some professionals said the popularity for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to fines, legal action or prison.
Platform Response and Material Removal
According to TikTok, the service has removed problematic material and prohibited related keywords and query recommendations. The organization stated it was dedicated to maintaining the service safe and investing in enhancing compliance measures.
Digital Trading Operations
Research also found groups with up to nine thousand participants marketing the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, populated with photos of slimming results, positive testimonials and detailed guides for mixing or injecting at home.
After moments of joining one group, a seller posted contact information, where most transactions occur. The vendor provided an guidebook and promised delivery within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, medical conditions or past usage.
Item Details and Pricing
Within these communities, messages show dark colored parcels with postal service labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for the messaging service said it actively moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting substances they cannot confirm. Although the research behind retatrutide is sound, these online versions may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her staff has previously seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject patients to potentially significant medical dangers”.
